ArticleRadiology case reports2026
Primary hepatic neuroendocrine tumor with multifocal liver involvement: A case report and review of the literature.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary hepatic neuroendocrine tumors (NETs) are extremely rare, representing approximately 0.3% of all NETs. We report the case of a 30-year-old woman who presented with asymptomatic abdominal distension. Imaging revealed multiple hepatic masses, the largest measuring 195 × 100 × 230 mm in the left lobe. Laboratory tests, including liver function and tumor markers, were normal. Histopathology and immunohistochemistry confirmed a well-differentiated grade 1 neuroendocrine carcinoma with positivity for synaptophysin, CD56, and chromogranin A and a Ki-67 index of 1%. A comprehensive workup excluded an extrahepatic primary tumor. The patient was treated with long-acting lanreotide, and follow-up imaging demonstrated stable lesions with minimal hormonal symptoms. This case highlights the diagnostic challenge of primary hepatic NETs, their often asymptomatic course, and the importance of multidisciplinary evaluation, histological confirmation, and targeted therapy, with surgical resection remaining the mainstay for localized disease while systemic therapy and interventional approaches may be considered in multifocal or unresectable cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.